Calcineurin differentially regulates maintenance and growth of phenotypically distinct muscles

被引:82
作者
Mitchell, PO
Mills, ST
Pavlath, GK
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[2] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2002年 / 282卷 / 05期
关键词
muscle precursor cells; myonuclear number; myofiber growth; cyclophilin;
D O I
10.1152/ajpcell.00483.2001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Adequate muscle mass is critical for human health. The molecular pathways regulating maintenance and growth of adult skeletal muscle are little understood. Calcineurin (CN) is implicated as a key signaling molecule in hypertrophy. Whether CN is involved in all forms of muscle growth or in different muscles is unknown. Here, we examine the role of CN in regulating maintenance of muscle size and growth of atrophied muscle in the soleus (slow) and plantaris (fast). The CN inhibitor cyclosporin A (CsA) differentially affects muscle growth and maintenance depending on muscle phenotype. The plantaris is more severely affected by CsA than the soleus in both growth conditions. One-week vs. 2-wk CsA treatment suggests that both CN-dependent and CN-independent growth occur in the atrophied soleus, whereas plantaris growth appears to be totally CN dependent. Our results suggest that CN regulates multiple types of muscle growth, depending both on muscle phenotype and stage of myofiber growth. Differential expression of components of the CN pathway occurs and may contribute to the differences between muscles.
引用
收藏
页码:C984 / C992
页数:9
相关论文
共 38 条
  • [1] Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells
    Abbott, KL
    Friday, BB
    Thaloor, D
    Murphy, TJ
    Pavlath, GK
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (10) : 2905 - 2916
  • [2] Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO
  • [3] 2-8
  • [4] Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells
    Avdonin, PV
    Cottet-Maire, F
    Afanasjeva, GV
    Loktionova, SA
    Lhote, P
    Ruegg, UT
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2407 - 2414
  • [5] Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301
  • [6] Quantitating immunosuppression - Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice
    Batiuk, TD
    Urmson, J
    Vincent, D
    Yatscoff, RW
    Halloran, PF
    [J]. TRANSPLANTATION, 1996, 61 (11) : 1618 - 1624
  • [7] Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype
    Bigard, X
    Sanchez, H
    Zoll, J
    Mateo, P
    Rousseau, V
    Veksler, V
    Ventura-Clapier, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) : 19653 - 19660
  • [8] Cellular adaptations of skeletal muscles to cyclosporine
    Biring, MS
    Fournier, M
    Ross, DJ
    Lewis, MI
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1998, 84 (06) : 1967 - 1975
  • [9] Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
    Bodine, SC
    Stitt, TN
    Gonzalez, M
    Kline, WO
    Stover, GL
    Bauerlein, R
    Zlotchenko, E
    Scrimgeour, A
    Lawrence, JC
    Glass, DJ
    Yancopoulos, GD
    [J]. NATURE CELL BIOLOGY, 2001, 3 (11) : 1014 - 1019
  • [10] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3